Beximco Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 6/6
Beximco Pharmaceuticals is a dividend paying company with a current yield of 4.85% that is well covered by earnings.
Key information
4.9%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 10.0% |
| Dividend Growth | 14.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €0.0335 |
| Payout ratio | 31% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: R2WA's dividends per share have been stable in the past 10 years.
Growing Dividend: R2WA's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Beximco Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (R2WA) | 4.9% |
| Market Bottom 25% (DE) | 1.7% |
| Market Top 25% (DE) | 4.8% |
| Industry Average (Pharmaceuticals) | 1.4% |
| Analyst forecast (R2WA) (up to 3 years) | 10.0% |
Notable Dividend: R2WA's dividend (4.85%) is higher than the bottom 25% of dividend payers in the German market (1.69%).
High Dividend: R2WA's dividend (4.85%) is in the top 25% of dividend payers in the German market (4.79%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (30.6%), R2WA's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (33.1%), R2WA's dividend payments are well covered by cash flows.